Sight Sciences Falls on Expected FY Revenue Decline

Dow Jones

Jan 14

By Elias Schisgall

Shares of Sight Sciences fell after the company said it expects its revenue in 2025 may have fallen year-over-year.

Shares were down 9.9% to $6.68 on Tuesday afternoon. The stock has doubled in value in the past year.

The eyecare technology company said Tuesday that it expects to report full-year revenue between $77.3 million and $77.4 million. At the midpoint, that would represent a 3% decrease compared to the previous year.

For the current fourth quarter, the company said it expects to report revenue between $20.3 million and $20.4 million, representing a 7% year-over-year increase at the midpoint.

Much of the full-year revenue decline was driven by the company's dry eye segment. Full-year revenue from that segment is expected to fall to about $1.6 million, compared with $4 million a year earlier.

Analysts surveyed by FactSet were expecting the company to report $20.2 million in revenue for the quarter and $77.1 million for the year.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

January 13, 2026 14:45 ET (19:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2603602637"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603602637\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603602637?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-14 03:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603602637","market":"fut","top_or_hot":-1,"title":"Sight Sciences Falls on Expected FY Revenue Decline","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Sight Sciences fell after the company said it expects its revenue in 2025 may have fallen year-over-year. \n</p>\n<p>\n  Shares were down 9.9% to $6.68 on Tuesday afternoon. The stock has doubled in value in the past year. \n</p>\n<p>\n  The eyecare technology company said Tuesday that it expects to report full-year revenue between $77.3 million and $77.4 million. At the midpoint, that would represent a 3% decrease compared to the previous year. \n</p>\n<p>\n  For the current fourth quarter, the company said it expects to report revenue between $20.3 million and $20.4 million, representing a 7% year-over-year increase at the midpoint. \n</p>\n<p>\n  Much of the full-year revenue decline was driven by the company's dry eye segment. Full-year revenue from that segment is expected to fall to about $1.6 million, compared with $4 million a year earlier. \n</p>\n<p>\n  Analysts surveyed by FactSet were expecting the company to report $20.2 million in revenue for the quarter and $77.1 million for the year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 13, 2026 14:45 ET (19:45 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sight Sciences Falls on Expected FY Revenue Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSight Sciences Falls on Expected FY Revenue Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-14 03:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Sight Sciences fell after the company said it expects its revenue in 2025 may have fallen year-over-year. \n</p>\n<p>\n  Shares were down 9.9% to $6.68 on Tuesday afternoon. The stock has doubled in value in the past year. \n</p>\n<p>\n  The eyecare technology company said Tuesday that it expects to report full-year revenue between $77.3 million and $77.4 million. At the midpoint, that would represent a 3% decrease compared to the previous year. \n</p>\n<p>\n  For the current fourth quarter, the company said it expects to report revenue between $20.3 million and $20.4 million, representing a 7% year-over-year increase at the midpoint. \n</p>\n<p>\n  Much of the full-year revenue decline was driven by the company's dry eye segment. Full-year revenue from that segment is expected to fall to about $1.6 million, compared with $4 million a year earlier. \n</p>\n<p>\n  Analysts surveyed by FactSet were expecting the company to report $20.2 million in revenue for the quarter and $77.1 million for the year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 13, 2026 14:45 ET (19:45 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGHT","symbol_name":"Sight Sciences, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2603602637","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603602637","pubTimestamp":1768333500,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Sight Sciences fell after the company said it expects its revenue in 2025 may have fallen year-over-year.Shares were down 9.9% to $6.68 on Tuesday afternoon. The stock has doubled in value in the past year.The eyecare technology company said Tuesday that it expects to report full-year revenue between $77.3 million and $77.4 million. At the midpoint, that would represent a 3% decrease compared to the previous year.For the current fourth quarter, the company said it expects to report revenue between $20.3 million and $20.4 million, representing a 7% year-over-year increase at the midpoint.Much of the full-year revenue decline was driven by the company's dry eye segment. Full-year revenue from that segment is expected to fall to about $1.6 million, compared with $4 million a year earlier.Analysts surveyed by FactSet were expecting the company to report $20.2 million in revenue for the quarter and $77.1 million for the year.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SGHT":"Sight Sciences, Inc."},"translate_title":"视觉科学因财年收入预期下降而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGHT":1.5},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Shares of Sight Sciences fell after the company said it expects its revenue in 2025 may have fallen year-over-year. \n\n\n  Shares were down 9.9% to $6.68 on Tuesday afternoon. The stock has doubled in value in the past year. \n\n\n  The eyecare technology company said Tuesday that it expects to report full-year revenue between $77.3 million and $77.4 million. At the midpoint, that would represent a 3% decrease compared to the previous year. \n\n\n  For the current fourth quarter, the company said it expects to report revenue between $20.3 million and $20.4 million, representing a 7% year-over-year increase at the midpoint. \n\n\n  Much of the full-year revenue decline was driven by the company's dry eye segment. Full-year revenue from that segment is expected to fall to about $1.6 million, compared with $4 million a year earlier. \n\n\n  Analysts surveyed by FactSet were expecting the company to report $20.2 million in revenue for the quarter and $77.1 million for the year. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 14:45 ET (19:45 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}